Does Rallies show 13F holders for PAVM?

Yes. Rallies tracks hedge fund and 13F ownership data for PAVM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PAVM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PAVM. It does not provide personalized investment advice.

PAVM (PAVmed Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

PAVmed Inc. Common Stock (PAVM) is a publicly traded Healthcare sector company. As of May 21, 2026, PAVM trades at $5.98 with a market cap of $45.16M and a P/E ratio of -1.08. PAVM moved -4.84% today. Year to date, PAVM is -17.01%; over the trailing twelve months it is -67.72%. Its 52-week range spans $6.00 to $43.44. Analyst consensus is buy with an average price target of $40.50. Rallies surfaces PAVM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PAVM stock?

Hedge funds tracked by Rallies that own PAVM include Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PAVmed Inc. Common Stock.

PAVM Key Metrics

Key financial metrics for PAVM
Metric	Value
Price	$5.98
Market Cap	$45.16M
P/E Ratio	-1.08
EPS	$-5.63
Dividend Yield	0.00%
52-Week High	$43.44
52-Week Low	$6.00
Volume	5
Avg Volume	0
Revenue (TTM)	$71.00K
Net Income	$-2.47M
Gross Margin	-207.04%

Top Hedge Funds Holding PAVM

Two Sigma holds 25.23K shares of PAVM, changed +0.00% as of Jun 30, 2024.

Latest PAVM News

PAVmed Q1 Loss of $4.42 EPS, $22K Revenue and $6.5M Cash — May 15, 2026
PAVmed Q1 GAAP Loss $7M, Cash Climbs to $6.5M; Lucid $1.3M Revenue — May 15, 2026
Lucid Diagnostics Closes $18M Equity Offering Anchored by $15M Institutional Investor — Apr 24, 2026
PAVmed Secures $45M Financing, Processes 3,664 EsoGuard Tests, Advances Device Pipeline — Mar 30, 2026

Recent PAVM Insider Trades

Glennon Michael J bought 100.00K (~$62.32K) on Dec 7, 2022.
Glennon Michael J bought 88.00K (~$56.08K) on Dec 6, 2022.
Glennon Michael J bought 62.00K (~$42.61K) on Dec 5, 2022.

PAVM Analyst Consensus

2 analysts cover PAVM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.50.

Common questions about PAVM

Who owns PAVM stock?: Hedge funds tracked by Rallies that own PAVM include Two Sigma. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PAVmed Inc. Common Stock.
Does Rallies show 13F holders for PAVM?: Yes. Rallies tracks hedge fund and 13F ownership data for PAVM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PAVM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PAVM. It does not provide personalized investment advice.